Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Duane Nash currently holds 300,000 shares of Akebia Therapeutics, Inc. (AKBA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Duane Nash has been a net seller of AKBA stock. They have purchased $125.0K and sold $606.1K worth of shares.
Duane Nash's most recent insider trade was on Dec 4, 2024, when they sold 300,000 shares at $0.00 per share.
Duane Nash serves as Executive at Akebia Therapeutics, Inc. (AKBA). They have executed 49 insider transactions totaling $731.1K over their tenure at the company.
Duane Nash holds the position of Executive at Akebia Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Duane Nash has shown a selling trading pattern, with $125.0K in total purchases and $606.1K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Duane Nash was on Dec 23, 2014, when they purchased $274.2K worth of AKBA shares. This transaction involved 23,762 shares at $11.54 per share.
Duane Nash currently owns 300,000 shares of Akebia Therapeutics, Inc. (AKBA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Duane Nash's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Duane Nash has 49 Form 4 filings on record as an insider at Akebia Therapeutics, Inc..
Set alerts for Duane Nash and 40,000+ other insiders.